피임약 시장 : 유형별, 투여 경로별, 연령층별, 유통 채널별, 지역별
Contraceptive Market, By Type, By Route of Administration, By Age Group, By Distribution Channel, By Geography
상품코드
:
1707287
리서치사
:
Coherent Market Insights
발행일
:
2025년 03월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
세계의 피임약 시장은 2025년에 197억 9,000만 달러에 달하고, 2032년에는 471억 4,000만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지의 연평균 성장률(CAGR)은 13.2%를 나타낼 전망입니다.
| 보고 범위 |
보고서 세부정보 |
| 기준 연도 |
2024년 |
시장 규모(2025년) |
197억 9,000만 달러 |
| 실적 데이터 |
2020-2024년 |
예측 기간 |
2025-2032년 |
| 예측 기간 : 2025-2032년 CAGR : |
13.20% |
가치 예측(2032년) |
471억 4,000만 달러 |
그림. 피임약 시장 점유율(%), 지역별(2025년)
세계의 피임약 시장은 지난 수십 년에 걸쳐 꾸준한 성장을 이루고 있습니다. 피임약은 일반적으로 여성 호르몬인 에스트로겐과 프로게스테론의 합성판을 포함하고 있습니다. 배란을 억제하고 자궁 경관 점액과 자궁 내막을 변화 가족계획에 대한 사고방식의 변화, 예정외의 임신에 대한 우려가 높아지고, 성건강에 대한 의식이 높아지고, 피임옵션에 관한 규제규범의 엄격화 등이 피임약 수요를 세계적으로 밀어 올리고 있습니다.
시장 역학 :
여성의 인식률이 높아지고 임파워먼트가 피임약 시장을 전진시키는 주요 요인입니다. 급속한 도시화, 라이프 스타일의 변화, 현대적인 건강 관리에 대한 쉬운 접근은 경구 피임약을 선택하는 여성을 늘리고 있습니다. 메트 메디컬 니즈를 해결하기 위한 기술 혁신과 마찬가지로, 효과성이 향상되고 부작용이 적은 신제품의 출현은 시장 기업에게 유리한 성장 기회를 만들어 냈습니다. 피임기구의 존재, 혈전, 우울증, 체중 변화 등 호르몬제에 따른 부작용이 시장 성장의 방해가 되고 있습니다. 또한, 일부 지역에서는 사회적 낙인이나 종교적 사양이 피임약 수요를 계속 억제하고 있습니다.
본 조사의 주요 특징
- 본 보고서에서는 세계의 피임약 시장을 상세하게 분석하여 2024년을 기준 연도로 한 예측기간(2025-2032년) 시장 규모 및 복합연간 성장률(CAGR)을 제공합니다.
- 또, 다양한 부문에 걸친 잠재적인 수익 성장 기회를 밝혀, 이 시장의 매력적인 투자 제안 매트릭스에 대해서 해설했습니다.
- 또, 시장 성장 촉진요인, 성장 억제요인, 기회, 신제품의 출시나 승인, 시장 동향, 지역별 전망, 주요 시장 기업이 채용하는 경쟁 전략 등에 관한 중요한 인사이트도 제공합니다.
- 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 파라미터에 근거해, 세계의 피임약 시장 주요 기업 프로파일을 제공합니다.
- 이 보고서의 인사이트는 마케팅 담당자와 기업 경영진이 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전술에 대한 정보를 바탕으로 의사 결정을 할 수 있게 합니다.
- 세계의 피임약 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통 업체, 신규 참가자, 재무 분석가 등이 업계의 다양한 이해 관계자에 대응하고 있습니다.
- 세계의 피임약 시장을 분석할 때 사용되는 다양한 전략 매트릭스를 통해 이해관계자는 의사결정이 용이해집니다.
제1장 조사의 목적과 전제조건
제2장 시장 전망
- 보고서 설명
- 주요 요약
- 일관된 기회 맵(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 피임약의 인기 증가
- 가족계획과 피임에 대한 접근을 촉진하기 위한 정부의 이니셔티브 확대
- 정제에 수반하는 부작용
- 혈전이나 심혈관 질환의 위험
- 신흥 국가 수요 증가
- 피임약을 선택하는 여성 인구 증가
- 주요 하이라이트
- 최근 동향
- PEST 분석
- PORTER 분석
- 최근 제품 승인/발매
- 합병, 인수 및 제휴
제4장 세계의 피임약 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향
- COVID-19 역학
- 공급측과 수요측의 분석
- 경제에 미치는 영향
제5장 세계의 피임약 시장, 유형별(2020-2032년)
- 복합 피임약
- 단상 알약
- 다상 알약
- 연장주기 알약
- 호르몬 피임약
- 프로게스틴 전용 알약
- 응급피임약
- 레보놀 게스트렐 기반
- 우리프리스탈 아세테이트베이스
제6장 세계의 피임약 시장, 투여 경로별(2020-2032년)
제7장 세계의 피임약 시장, 연령층별(2020-2032년)
제8장 세계의 피임약 시장, 유통 채널별(2020-2032년)
제9장 세계의 피임약 시장, 지역별(2020-2032년)
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동
- 아프리카
제10장 경쟁 구도
- 기업 프로파일
- Bayer AG
- Pfizer Inc.
- Teva Pharmaceutical Industries
- Merck &Co.
- Janssen Pharmaceutical Companies
- Allergan
- Piramal Enterprises
- Glenmark Pharmaceuticals
- Lupin Pharmaceuticals
- Mylan Pharmaceuticals
- Mithra Pharmaceuticals
- Gedeon Richter
- HLL Lifecare
- Cadila Healthcare
- Organon
- Other Prominent Players
제11장 섹션
KTH
영문 목차
Global Contraceptives Market is estimated to be valued at USD 19.79 Bn in 2025 and is expected to reach USD 47.14 Bn by 2032, growing at a compound annual growth rate (CAGR) of 13.2% from 2025 to 2032.
| Report Coverage |
Report Details |
| Base Year: |
2024 |
Market Size in 2025: |
USD 19.79 Bn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: |
13.20% |
2032 Value Projection: |
USD 47.14 Bn |
Figure. Contraceptives Market Share (%), By Region 2025
Global contraceptive pill market has been witnessing steady growth over the past few decades. Contraceptive pills, commonly known as birth control pills, contain synthetic versions of the female sex hormones - estrogen and progesterone. They are taken orally to prevent pregnancy by inhibiting ovulation and altering cervical mucus and the lining of the uterus. Changing attitudes towards family planning, rising concern about unplanned pregnancies, growing sexual health awareness, and stricter regulatory norms regarding contraceptive options have boosted the demand for contraceptive pills globally. Moreover, increasing women workforce participation and delayed pregnancies have further augmented the acceptance of oral contraceptive drugs.
Market Dynamics:
Rising female literacy and empowerment are the primary drivers propelling the contraceptive pill market forward. Growing awareness about women's reproductive health and rights has led to a widespread acceptance of contraceptives to delay or plan pregnancies. Rapid urbanization, changing lifestyles, and easier access to modern healthcare are encouraging more women to opt for oral contraceptives. At the same time, the emergence of new products with improved efficacy and fewer side effects as well as innovations to address unmet medical needs in contraception are creating lucrative growth opportunities for market players. However, the presence of alternative family planning methods and contraceptive devices along with some side effects that are associated with hormonal pills such as blood clots, depression, and weight changes are hindering the market growth. Moreover, social stigma and religious reservations in some regions continue to restrain the demand for contraceptive pills.
Key Features of the Study:
- This report provides an in-depth analysis of the global contraceptive market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key market players
- It profiles key players in the global contraceptive market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Bayer AG, Pfizer Inc., Teva Pharmaceutical Industries, Merck & Co., Janssen Pharmaceutical Companies, Allergan, Piramal Enterprises, Glenmark Pharmaceuticals, Lupin Pharmaceuticals, Mylan Pharmaceuticals, Mithra Pharmaceuticals, Gedeon Richter, HLL Lifecare, Cadila Healthcare, Organon and Other Prominent Players
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global contraceptive market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global contraceptive market
Detailed Segmentation:
- Global Contraceptive Market, By Type
- Combination Contraceptives
- Monophasic pills
- Multiphasic pills
- Extended-cycle pills
- Hormonal Contraceptives
- Progestin-Only Pills
- Emergency Contraceptives
- Levonorgestrel-based
- Ulipristal acetate-based
- Global Contraceptive Market, By Route of Administration
- Oral
- Injectable
- Intrauterine
- Vaginal
- Others (Patches, etc.)
- Global Contraceptive Market, By Age Group
- Global Contraceptive Market, By Distribution Channel
- Online Pharmacies
- Hospital Pharmacies
- Retail Pharmacies
- Global Contraceptive Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
- Company Profiles
- Bayer AG
- Pfizer Inc.
- Teva Pharmaceutical Industries
- Merck & Co.
- Janssen Pharmaceutical Companies
- Allergan
- Piramal Enterprises
- Glenmark Pharmaceuticals
- Lupin Pharmaceuticals
- Mylan Pharmaceuticals
- Mithra Pharmaceuticals
- Gedeon Richter
- HLL Lifecare
- Cadila Healthcare
- Organon
- Other Prominent Players
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Type
- Market Snippet, By Route of Administration
- Market Snippet, By Age Group
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increasing popularity of contraceptive drugs
- Growing government initiatives for promoting access to family planning and contraceptives
- Side effects associated with pills
- Risks of blood clots and cardiovascular diseases
- Growing demand in developing countries
- Growing female population opting for contraceptive drugs
- Key Highlights
- Recent Trends
- PEST Analysis
- PORTER's Analysis
- Recent Product Approvals/Launches
- Mergers, Acquisitions, and Collaborations
4. Global Contraceptive Market- Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Contraceptive Market, By Type, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Combination Contraceptives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Monophasic pills
- Multiphasic pills
- Extended-cycle pills
- Hormonal Contraceptives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Progestin-Only Pills
- Emergency Contraceptives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Levonorgestrel-based
- Ulipristal acetate-based
6. Global Contraceptive Market, By Route of Administration, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Intrauterine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Vaginal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Others (Patches, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
7. Global Contraceptive Market, By Age Group, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Adolescents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
8. Global Contraceptive Market, By Distribution Channel, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
9. Global Contraceptive Market, By Region, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2032
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profile
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Janssen Pharmaceutical Companies
- Allergan
- Piramal Enterprises
- Glenmark Pharmaceuticals
- Lupin Pharmaceuticals
- Mylan Pharmaceuticals
- Mithra Pharmaceuticals
- Gedeon Richter
- HLL Lifecare
- Cadila Healthcare
- Organon
- Other Prominent Players
- Analyst Views
11. Section
- References
- Research Methodology
- About us
관련자료
